Lexeo Therapeutics, Inc. Common Stock
Biotechnology
Healthcare
LXEO
33.11 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.36
52 week high
11.12
high
5.49
52 week low
0.00
low
5.17
growth
-50.37 %
previous Close
5.31
P/E ratio
market cap
245 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top